PARATHYROID HORMONE (PTH) A new class of osteoporosis treatments called bone formation agents Parathyroid hormone analogues belong to a class of osteoporosis medications which can promote bone growth. In Canada, […]

BISPHOSPHONATES The most common family of drugs used to treat osteoporosis Bisphosphonates are the most common family of drugs used to treat osteoporosis. They are part of the group of […]

Bisphosphonate therapy – long term use Recently a study published by Drieling et al in JAGS 2017 described the results of a cohort study of 5120 older women with an […]

The recent study by Bolland and colleagues published in the Lancet Diabetes Endocrinology (Oct 4, 2018) is an updated meta-analysis that evaluated the effects of vitamin D supplementation on fractures, […]

The Osteoporosis Exemplary Care Program (OECP) at St. Michael’s Hospital in Toronto, Ontario has been a leader in the FLS movement in Canada and worldwide. OECP was founded in 2002 […]

St. Clare’s Mercy Hospital in Newfoundland and Labrador St. Clare’s Mercy Hospital in Newfoundland and Labrador Breakfree Fracture Liaison Service (FLS) established in March 2024 New Breakfree Fracture Liaison Service […]

Latest News A New Clinical Practice Guideline for management of osteoporosis and fracture prevention in Canada October 10, 2023 On October 10, 2023, a new guideline on managing osteoporosis to […]

Osteoporosis Canada is pleased to announce that effective November 1, 2023 Dr. Sonia Singh will be joining the organization as the new OC National FLS Implementation Lead, previously known as […]

Donate Today Your gift will immediately help to educate, empower, and support individuals and communities on bone health and in the risk-reduction and treatment of osteoporosis. Donate Cook With OC […]